Publication Source Archive: Law360

Thursday’s testimony came from Angela Feniger, Par’s former DEA compliance director, who is now an associate director of technical writing and quality assurance at the drugmaker. In 2010, she testified that Par hired outside consultants to conduct an internal audit of the company’s compliance with the agency processes. “And the point of the audit was…Read the article

Napoli Shkolnik PLLC partner Matthew Lavin, who represents patients who have been denied insurance coverage for mental health treatment, said the feedback he’s gotten from “hundreds of clients” is that UBH still isn’t fully covering substance abuse treatment. Under UBH’s current guidelines, developed by the American Society of Addiction Medicine, it should cover multiple types…Read the article

The New York judge overseeing the state’s trial over the opioid crisis on Monday ordered Endo Pharmaceuticals and its firm Arnold & Porter to explain discovery violations and why Endo shouldn’t be hit with a default judgment for its liability for the epidemic, following accusations of discovery cover-up in separate cases. “The depth of the deceit…Read the article

The New York attorney general and six other state attorneys general on Wednesday formally announced a global opioid settlement worth $26 billion with Johnson & Johnson and the nation’s three largest drug distributors. A trial over the New York state and two Long Island counties’ opioid suit (Nassau County is a client of Napoli Shkolnik)…Read the article

As part of an upcoming nationwide settlement, the nation’s three largest drug distributors on Tuesday struck a $1.1 billion opioid deal with New York’s attorney general and exited a closely watched jury trial. “Unlike the national deal, it is not contingent on the rest of the country or other states joining,” Hunter Shkolnik of Napoli…Read the article

And so Tuesday’s opening statements served up easily digestible charts, graphics and pictures seasoned very lightly with the underlying legal issues, such as drug company obligations under the Controlled Substances Act to watch for suspicious opioid orders. Hunter Shkolnik, for example, presented the jurors with an AmerisourceBergen Corp. investigator’s email that had the subject line…Read the article

“First and foremost, this is an opioid epidemic. Don’t let anyone try to convince you otherwise. There is a clear opioid epidemic in our community in Nassau, Suffolk Counties, the state of New York and the rest of the United States,” Shkolnik said. “The opioid epidemic didn’t happen by accident.” “When each of these defendants…Read the article

Law360 quoted Hunter Shkolnik after Walmart, CVS and Rite Aid were been severed from New York state and two Long Island counties’ swiftly approaching opioid trial. “Judgment day is coming,” Hunter Shkolnik of Napoli Shkolnik PLLC, counsel for Nassau County, told Law360. DownloadRead the article

A monumental opioid trial pitting New York state and two local governments against a dozen drug companies is being pushed back nearly one week because jury selection is taking longer than expected, sources said Wednesday. Napoli Shkolnik PLLC partner Hunter Shkolnik, counsel for Nassau County, one of the trial’s three government plaintiffs, also confirmed the…Read the article

The West Virginia Supreme Court on Friday ruled that the state and cities’ claims in consolidated litigation that drug companies’ marketing of opioids created a public nuisance can proceed to trial before a jury. “We are extremely pleased the West Virginia Supreme Court has stepped in and made clear our counties are entitled to go…Read the article